HRT and fatty liver disease in menopausal women – a pilot study
Treatments studied
Part of Digestive system clinical trials.
This study tests whether starting hormone replacement therapy (HRT) improves liver health in women with menopause and fatty liver disease (MASLD). It aims to understand how HRT might help reduce fat in the liver.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older
- You have gone through menopause (no periods for at least a year, or had your ovaries removed)
- You have fatty liver disease (MASLD) but no other liver disease
- You have not used hormone replacement therapy (HRT) in the last 3 months
- You weigh between BMI 18 and 45 – this covers most body sizes
- You are willing to have an MRI scan and receive information about the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the time of day you exercise affects liver fat and overall health in postmenopausal women with fatty liver disease. It may help you find a simple way to improve your liver health without medication.
This study tests a more detailed way to examine the liver in people with fatty liver disease who also have other health risks. The doctors want to see if this extra testing helps decide whether you need treatment.
This trial tests new medicines for adults with fatty liver disease (MASLD) that has already caused some liver scarring. It aims to see if these drugs can help prevent the liver disease from getting worse.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
This trial tests a new medication for people with fatty liver disease. It will see if the drug can reduce liver fat and improve liver health over several doses.
This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.
Hear when a new Menopause trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.